HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Influence of aminophylline and 8-(p-sulfophenyl)theophylline on the anticonvulsive action of diphenylhydantoin, phenobarbital, and valproate against maximal electroshock-induced convulsions in mice.

Abstract
Aminophylline (theophylline2.ethylenediamine) in the dose of 12.5 mg/kg (i.p.) was ineffective upon all antiepileptic drugs studied and at the higher dose of 25 mg/kg, impaired the anticonvulsant action of phenobarbital and valproate against maximal electroshock in mice. The protection offered by diphenylhydantoin was diminished by aminophylline at 50 mg/kg (0.238 mmol of anhydrous theophylline/kg). In contrast, 8-(p-sulfophenyl)theophylline (a theophylline derivative unable to cross the blood-brain barrier) in the dose of 80 mg/kg (0.238 mmol/kg) did not influence the protective activity of diphenylhydantoin, phenobarbital, and valproate. It might be concluded that the aminophylline-induced impairment of the anticonvulsant action of common antiepileptic drugs results from the central effects of this methylxanthine.
AuthorsK Borowicz, M Kozicka, Z Kleinrok, S J Czuczwar
JournalJournal of neural transmission. General section (J Neural Transm Gen Sect) Vol. 93 Issue 2 Pg. 157-63 ( 1993) Austria
PMID8217053 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anticonvulsants
  • Aminophylline
  • Valproic Acid
  • Phenytoin
  • 8-(4-sulfophenyl)theophylline
  • Theophylline
  • Phenobarbital
Topics
  • Aminophylline (pharmacology)
  • Animals
  • Anticonvulsants (antagonists & inhibitors, pharmacology)
  • Dose-Response Relationship, Drug
  • Electroshock
  • Male
  • Mice
  • Phenobarbital (antagonists & inhibitors, pharmacology)
  • Phenytoin (antagonists & inhibitors, pharmacology)
  • Seizures (prevention & control)
  • Theophylline (analogs & derivatives, pharmacology)
  • Valproic Acid (antagonists & inhibitors, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: